Ruxolitinib-[d4]

Ask supplier a question | View on supplier's website

A deuterated ruxolitinib. Ruxolitinib is a janus-associated kinase inhibitor indicated to treat bone marrow cancer, specifically intermediate or high-risk myelofibrosis.

Supplier	BOC Sciences
Product #	BLP-005995
Pricing	Inquire
Molecular Weight	310.39
Molecular Formula	C17H14D4N6
Canonical SMILES	C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3

Feedback